Regen BioPharma (United States)

Distribution of the Tetrodotoxin-Resistant Sodium Channel PN3 in Rat Sensory Neurons in Normal and Neuropathic Conditions

Sanja D. Novaković, Elda Tzoumaka, Joseph G. McGivern et al. · Journal of Neuroscience · 1998 · 368 citations · Full text

Pathogenesis of Sudden Unexpected Death in a Clinical Trial of Patients With Myocardial Infarction and Left Ventricular Dysfunction, Heart Failure, or Both

Anne–Catherine Pouleur, Ebrahim Barkoudah, Hajime Uno et al. · Circulation · 2010 · 217 citations · Full text

Effect of the REG1 anticoagulation system versus bivalirudin on outcomes after percutaneous coronary intervention (REGULATE-PCI): a randomised clinical trial

A. Michael Lincoff, Roxana Mehran, Thomas J. Povsic et al. · The Lancet · 2015 · 143 citations

Thrombosis, Percutaneous Coronary Intervention, Reg1 Anticoagulation System +11

A Phase 2, randomized, partially blinded, active-controlled study assessing the efficacy and safety of variable anticoagulation reversal using the REG1 system in patients with acute coronary syndromes: results of the RADAR trial

Thomas J. Povsic, John P. Vavalle, Laura H. Aberle et al. · European Heart Journal · 2012 · 105 citations · Full text

Hyperplastic Changes within the Leptomeninges of the Rat and Monkey in Response to Chronic Intracerebroventricular Infusion of Nerve Growth Factor

P A Day-Lollini, Gregory R. Stewart, Michael J. Taylor et al. · Experimental Neurology · 1997 · 68 citations

Neuropeptides, Neurophysiology, Neuroanatomy +12